ABSTRACT: In Exp.
Introduction
The majority of the luteal phases that follow ovulations induced by early weaning (Odde et al., 1980) and GnRH treatment (Webb et al., 1977; Lishman et al., 1979; Fonseca et al., 1980; Kesler et al., 1980) are 6 to 12 d long. When cows have been bred a t an estrus with an expected subsequent short luteal phase, conception may occur but pregnancy is generally not maintained (Ramirez-Godinez et al., 1982; Kesler and Troxel, 1984) . Norgestomet treatment before early weaning (Ramirez-Godinez et al., 1982) and GnRH treatment (Kesler and Troxel, 19841 , however, has reduced the incidence of short luteal phases. In addition, pregnancy has been achieved in pretreatment, anestrous, postpartum suckled beef cows treated with a procedure, SyncroMate B (Sanofi Animal Health, Overland Park, KS) , that employs norgestomet treatment . Smith et al. (1979) improved pregnancy rates in anestrous, postpartum beef cows treated with Syncro-Mate B by incorporating short-term calf removal (48 to 60 h ) near the time of norgestomet implant withdrawal.
The mechanisms by which norgestomet reduces the incidence of short luteal phases and improves pregnancy rates in anestrous, postpartum, suckled beef cows are not fully understood. The presence of luteolytic prostaglandins and shortened preovulatory LH surges have been shown to be causes of short luteal phases (Troxel and Kesler, 1984a, b; Vincent et al., 1984) . Norgestomet treatment before GnRH administration enhances the GnRH-induced LH release and lowers concentrations of prostaglandin metabolites in anestrous, postpartum, suckled beef cows (Troxel and Kesler, 1984b) .
Because Troxel and Kesler (1984b) demonstrated that norgestomet therapy before GnRH treatment induced a high percentage of ovulations that were followed by normal luteal phases, we speculated that the combination would present a favorable situation for pregnancy in a high percentage of similarly treated cows. The use of GnRH could be of particular value in postpartum, anestrous cows to induce ovulation. The use of GnRH could be of value in cows that already exhibit estrous cycles by inducing the preovulatory surge a t a more uniform and desirable time relative to the timed breeding. Troxel and Kesler (198413) used the combination of norgestomet and GnRH but only determined the ovulation response and corpus luteum function. Troxel and Kesler (1984b) did not evaluate fertility and pregnancy subsequent to the combined norgestomet and GnRH treatments.
The objective of these experiments was to determine the efficacy of norgestomet and GnRH treatments to induce fertile ovulations in pretreatment anestrous and cyclic postpartum suckled beef cows.
Materials and Methods
Experiment I. One hundred one postpartum suckled beef cows from the University of Illinois Dixon Springs Agricultural Center were used in this experiment. Calving occurred from February to April and the number of days postpartum to the timed AI ranged from 25 to 90 d. All cows were managed similarly. Cows were pastured on fescue with access to corn silage or fescue hay. Cows were predominantly Hereford and Angus cows that were 2 to 10 yr of age and weighed 420 to 510 kg.
To synchronize estrus, all cows received two injections of prostaglandin F2a ( PGF2,) 11 d apart (25 mg per injection, Lutalyse; The Upjohn Co., Kalamazoo, MI). Cows were then randomly assigned to one of three treatment groups and were maintained as a single group throughout the experimental period. Cows assigned to Group 1 ( n = 34) served as controls.
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Cows assigned to Group 2 ( n = 34) received GnRH (250 pg) subcutaneously in a gelatin capsule and short-term calf removal (47 h ) , and cows assigned to Group 3 ( n = 33) received a norgestomet ear implant ( 6 mg) for 8 d, GnRH in a gelatin capsule, and shortterm calf removal. The GnRH was administered 30 h after implant removal to correspond to the approximate time of early estrus and the spontaneous LH surge in cows synchronized with the norgestomet implant in the Syncro-Mate B procedure . The time schedule of the treatments is shown in Figure 1 . The norgestomet ear implants were inserted 4 d after the first PGF2, injection (Group 3). The norgestomet implants and calves (Groups 2 and 3 ) were removed 28 h after the second PGFza injection. Calves that were not removed (Group 1) were allowed to nurse ad libitum throughout the experimental period. The GnRH (250 pg subcutaneously in a gelatin capsule) was administered 58 h after the second PGFza injection or 30 h after the time of the norgestomet implant (Group 3) and calf removal (Groups 2 and 3). Calves were moved t o a location out of sight and sound of their dams. Lyophilized GnRH was placed in the gelatin capsule, and the capsules were maintained moisture-free at -20°C from the time of manufacturing the capsules until they were implanted into the cows. The GnRH gelatin capsules were inserted behind the shoulder of the treated cows. A small incision was made through the skin with a scalpel, and the gelatin capsule was inserted with the assistance of hemostats. A small amount of antibiotic was applied to the incision site after capsule insertion. All cows were artificially inseminated once 75 h after the second PGFza injection. .The calves of the calf removal groups (Groups 2 and 3 ) were returned to their dams after the timed insemination. Semen used at the timed breeding was from commercial bull studs and was from bulls of breeds different from the breeds of the bulls used for natural service. Eighteen days after the timed AI, bulls were placed in pastures with the cows for 62 d. Pregnancy to the timed AI was determined by calving. Pregnancy data were not obtained from four cows that died during the winter. All cows were administered treatments as one group such that they were all inseminated on the same day.
Blood was collected via jugular venipuncture 10 d before the first PGF2,y injection, immediately before each PGF2, injection, and on d 5 or 6 , 10 or 11, and 14 or 15 after the time of GnRH treatment. Blood samples were placed in crushed ice immediately after collection and serum was separated by centrifugation (2,000 x g ) . Blood samples were centrifuged within 6 h of collection. The serum was frozen at -20°C until it was assayed. All samples were assayed for concentrations of progesterone by RIA. Progesterone concentrations from blood samples taken before the second PGF2, injection (three samples) were used to determine the pretreatment reproductive status of each cow (anestrous or cyclic). Cows were classified as cyclic if any of the three blood samples had progesterone concentrations > 1.0 ng/mL. The blood samples taken on d 5 or 6, 10 or 11, and 14 or 15 after the time of GnRH treatment were used to determine ovulation response and subsequent corpus luteum function. Cows were considered to have ovulated if progesterone concentrations were > .5 ng/mL on d 5 or 6. This has been demonstrated to be indicative of an ovulation induced by GnRH in anestrous, postpartum suckled beef cows . Cows classified as ovulated were considered to have an abnormal luteal phase if progesterone concentrations decreased to < 1.0 ng/mL on d 10 to 15 after the time of GnRH treatment. These classifications were previously described and determined to be adequate methods of detecting ovulation and short luteal phases by Kesler et al. (1981) .
Experiment 2. One hundred seventy-four postpartum suckled beef cows from the University of Illinois Dixon Springs Agricultural Center were assigned to a 2 x 2 factorial experiment with reproductive status (anestrous and cyclic) and GnRH (none or 250 pg) as the main effects. Calving occurred in February to May and the number of days postpartum to the timed artificial breeding ranged from 25 to 90 d. All cows were managed similarly. Cows were pastured on fescue with access to corn silage or fescue hay.
Estrus was synchronized in all cows at the same time with Syncro-Mate B. The Syncro-Mate B procedure consists of an intramuscular injection of norgestomet ( 3 . 0 mg) and estradiol valerate ( 5 . 0 mg) in a sesame oil and benzyl alcohol (10%) carrier and a hydron ear implant that contains 6.0 mg of norgestomet. The implant was subcutaneously implanted on the convex surface of the ear and left in situ for 9 d. At the time of implant removal the cows were randomly assigned to treatment groups. Cows assigned to receive GnRH received 250 pg intramuscularly (dissolved in 5 mL of a potassium phosphate buffer) approximately 30 h after Syncro-Mate B implant removal. Cows in the control group received an injection of the carrier for GnRH. All cows were artificially inseminated with semen from commercial bull studs approximately 47 h after Syncro-Mate B implant removal (46 to 48 h ) . Semen from several bulls was used, and cows were bred to predetermined bulls. Bull selection was determined before randomly assigning the cows to their treatment group in this study. Cows were inseminated by one inseminator. The semen used at AI was from bulls of breeds different from the breeds of bulls used for natural service. Eighteen days after the timed AI, bulls were placed in pastures with the cows for 62 d. Pregnancy data reported in the results were based on calving data.
Blood samples were collected 10 d before and immediately before Syncro-Mate B treatment. Blood samples were placed in crushed ice immediately after collection and serum was separated by centrifugation (2,000 x 9 ) . Blood samples were centrifuged within 6 h of collection. The serum was frozen a t -20°C until it was assayed. All serum samples were assayed for progesterone concentrations by RIA. Cows were considered cyclic if either one or both of the blood samples had progesterone concentrations > 1.0 ngImL.
Progesterone Assay. Serum progesterone concentrations were determined by RIA according to procedures previously described and validated in our laboratory (Wiseman et al., 1983) . Samples were assayed in duplicate and all samples from one cow were determined in one assay. Intraassay and interassay CV were 8.0 and 11.1%. The mean of the pooled samples was 2.7 f .2 ng/mL. All samples were adjusted for recovery (91.9 f 1.4%).
Statistical Analysis. Duplicate estimates of hormone concentrations were averaged before analysis. The ovulation response, incidence of abnormal luteal phases, and the timed breeding pregnancy rates were analyzed by chi-square analysis as described by Cochran and Cox (1957) .
Results and Discussion
Experiment 1. Sixty-two percent ( n = 6 3 ) of the cows were classified anestrous and 38% ( n = 38) cyclic before the time of second PGFzcy injection. The final number of cows per treatment group are reported in Tables 1 and 2 .
The number of cows that ovulated after the time of GnRH treatment and the number of cows with abnormal luteal phases per treatment group for the pretreatment anestrous and cyclic cows are reported in Table 1 . The number of pretreatment anestrous cows that ovulated after the time of GnRH treatment was greater ( P < .Ol) for GnRH-treated cows (Groups 2 and 3 ) than for untreated cows (Group 1 ) . There were no differences ( P > . l o ) between treatment groups in the number of pretreatment cyclic cows that ovulated after the time of GnRH treatment ( Table 1) .
The pretreatment anestrous cows treated in Group 3 had a reduced incidence of abnormal luteal phases ( P < .01) compared with the pretreatment anestrous cows treated in Group 2. There were no abnormal luteal phases detected in any of the pretreatment cyclic cows (Table 1 ) .
The timed breeding pregnancy rates of the pretreatment anestrous and cyclic cows are reported in Table   2 . The timed breeding pregnancy rate was greater ( P < .01) for the pretreatment anestrous cows of Group 3 than for cows in Groups 1 and 2. There was also a difference between the timed breeding pregnancy rates among the treatment groups for the pretreatment cyclic cows. The timed breeding pregnancy rate of the norgestomet-treated cows was higher ( P < .05) than the timed breeding pregnancy rate of the control and GnRH-treated pretreatment cyclic cows. When pretreatment anestrous and cyclic cows were com-ET AL.
bined, there was a significant ( P < .05) improvement in pregnancy rates due to norgestomet.
In all cases the cows that became pregnant to the timed AI were classified both as ovulated and as not having a short luteal phase, which supports the classification scheme used. The pregnancy rates for the timed AI for only cows that ovulated and had a normal luteal phase are reported in Table 3 . Pregnancy rates were similar for all three groups of presynchronization anestrous cows. Norgestomet tended ( P < .08) to improve the pregnancy rates for the presynchronization cyclic cows.
This experiment was designed to test the efficacy of norgestomet on enhancing corpus luteum lifespan and subsequent fertility. To increase the chance of success the GnRH was administered in an excipient that has been demonstrated to prolong the GnRH-induced LH surge (Vincent et al., 1984) . Based on previous studies (Smith et al., 19791 , calves were removed a t approximately the time of norgestomet implant removal again in an attempt to increase the chance of success. The results of this study demonstrate that the success of GnRH in inducing ovulation in anestrous cows is repeatable. The subsequent luteal phase was short in 78% of the cases unless norgestomet treatment was imposed before GnRH treatment. The addition to norgestomet reduced the incidence of short luteal phases to 21%. This, however, was still not equal to the incidence observed in cyclic cows (0%). 
(0%)
aAs determined by three blood progesterone determinations (10 d before the first PGF2, injection, and immediately before both PGFz, injections). If all determinations had progesterone concentrations < 1.0 ng/mL they were considered anestrous. Otherwise they were classified as cyclic.
bTwo injections of PGF2, were administered 11 d apart to all cows. CGnRH was administered to cows in Groups 2 and 3, 58 h after the second PGF2, injection. Cows in Groups 2 and 3 also had their calves removed for 47 h beginning a t the time of norgestomet implant removal.
dCows were considered to have ovulated if progesterone concentrations were > .5 ng/mL on d 5 or 6 after GnRH treatment. Cows classified as ovulated were considered to have an abnormal luteal phase if progesterone concentrations decreased to < 1.0 ng/mL on d 10 or 11 or d 14 or 15 after GnRH treatment. eCows in Group 3 were administered a norgestomet implant 4 d after the first PGFaa injection that was left in situ for 8 d.
f,gValues in a row with different superscripts differ ( P < ,011. aAs determined by three blood progesterone determinations ( 10 d before the first PGF2, injection, and immediately before both PGFz, injections). If all determinations had progesterone concentrations < 1.0 ng/mL they were considered anestrous. Otherwise they were classified as cyclic.
bTwo injections of PGFza were administered 11 d apart to all cows. CGnRH was administered to cows in Groups 2 and 3 58 h after the second PGFzu injection. Cows in Groups 2 and 3 also had their calves removed for 47 h beginning at the time of norgestomet implant removal. dCows in Group 3 were administered a norgestomet implant 4 d after the first PGFzu injection that was left in situ for 8 d.
efValues across rows with different superscripts differ ( P < ,011. FhValues across rows with different superscripts differ ( P < ,051.
'Numbers differ from Table 1 because four cows died during the winter.
No. of cyclic cows
No. of cows combined Table 3 . The number of presynchronization anestrous and cyclica postpartum beef cows that became pregnant to the timed insemination (only for cows that ovulated and had a normal luteal phaseb) after PGFza synchronizationC and norgestomet and(or) GnRH treatments in Experiment aAs determined by three blood progesterone determinations (10 d before the first PGF2, injection, and immediately before both PGFza injections). If all determinations had progesterone concentrations < 1.0 ng/mL they were considered anestrous. Otherwise they were classified as cyclic.
hCows were considered to have ovulated if progesterone concentrations were > .5 ng/mL on d 5 or 6. Cows classified as ovulated were considered to have an abnormal luteal phase if progesterone concentrations decreased to < 1.0 ng/mL on d 10 or 11 or d 14 or 15.
cTwo injections of PGFza were administered 11 d apart to all cows.
d G~R H was administered to cows in Groups 2 and 3 58 h after the second PGFza injection. Cows in Groups 2 and 3 also had their calves removed for 47 h beginning at the time of norgestomet implant removal.
eCows in Group 3 were administered a norgestomet implant 4 d after the first PGFza injection that was left in situ for 8 d. fDiffers ( P < . O S ) from Group 3. gDiffers ( P < .05) from Group 3. aAs determined by three blood progesterone determinations (10 d before the first PGF2, injection, and immediately before both PGF2, injections). If all determinations had progesterone concentrations < 1.0 ng/mL they were considered anestrous. Otherwise they were classified as cyclic.
bGnRH was administered 30 h after Syncro-Mate B implant removal. 'Pregnancy rate was determined by cahing.
dValues across rows differ ( P < .05). eValues across rows differ ( P < .01).
Subsequent fertility was measured by breeding the cows 17 h after the time of GnRH administration. Pregnancy rates were unchanged when cows received GnRH and calf removal along with the PGFao, for estrus synchronization. When norgestomet was also included before GnRH treatment, fertility was not only increased in the pretreatment anestrous cows but also in the pretreatment cyclic cows. The pregnancy rates to the timed AI were nearly doubled due to norgestomet pretreatment. The increase in the norgestomet pretreatment anestrous cows could be due to the reduced incidence of short luteal phases because the pregnancy rates of the cows that ovulated and had a normal luteal phase were similar for all three groups. However, because there were no short luteal phases in the cyclic cows, there are probably other explanations.
Experiment 2. Forty-nine percent ( n = 85) of the cows were classified as being anestrous and 51% ( n = 89) were classified as being cyclic before Syncro-Mate B treatment. The final numbers of cows per treatment group are reported in Table 4 .
The timed breeding pregnancy rates for the presynchronization anestrous and cyclic cows are reported in Table 4 . The timed breeding pregnancy rate was greater ( P < . 0 5 ) for the GnRH-treated, presynchronization anestrous cows than for the controls. The timed breeding pregnancy rate for the GnRH-treated, presynchronization cyclic cows was also higher ( P < . 0 1 ) than for the control presynchronization cyclic cows. When combined, there was a significant ( P < .01) improvement in pregnancy rates due to GnRH.
Several factors may have confounded the fertility results of Exp. 1. The foremost question was whether GnRH was needed at all. Experiment 2 was designed to be more practical in nature and to determine the efficacy of GnRH after norgestomet treatment. SyncroMate B is a commercial estrus synchronization procedure that includes norgestomet treatment. Therefore, in Exp. 2 all cows were administered Syncro-Mate B and then divided into two groups: one that received GnRH and the other that served as a control group. Short-term calf removal was not included, again in an attempt to be more practical. The GnRH was more conveniently administered as an intramuscular injection rather than in a gelatin capsule but still at the 250 pg amount. Results clearly demonstrated the efficacy of GnRH. Pregnancy rates subsequent to synchronization were more than doubled by GnRH treatment.
Collectively these results demonstrate the efficacy of norgestomet in reducing the incidence of short luteal phases. Further, administration of GnRH subsequent to synchronization using norgestomet enhanced pregnancy rates to a timed insemination.
Implications
The use of norgestomet in estrus synchronization enhances subsequent fertility of presynchronization anestrous cows by reducing the incidence of short luteal phases. Norgestomet also enhanced subsequent fertility of presynchronization cyclic cows. Norgestomet is already incorporated into an estrus synchronization program (Syncro-Mate B), but the addition of gonadotropin releasing hormone 30 h after the norgestomet implant removal may further improve fertility subsequent to Syncro-Mate B synchronization.
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